Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of California at San Francisco
mi
from
San Francisco, CA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of Colorado
mi
from
Aurora, CO
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Henry Ford Health System
mi
from
Detroit, MI
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load
Status: Enrolling
Updated:  9/26/2015
National Naval Medical Center
mi
from
Bethesda, MD
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load
Status: Enrolling
Updated: 9/26/2015
National Naval Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
Studies of Lymphocyte Kinetics Using Bromodeoxyuridine
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
Studies of Lymphocyte Kinetics Using Bromodeoxyuridine
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy
Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy
Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Screening HIV-Infected Patients for Vaccine Studies
Screening HIV-Infected Subjects for Vaccine Research Studies
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening HIV-Infected Patients for Vaccine Studies
Screening HIV-Infected Subjects for Vaccine Research Studies
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations
Status: Enrolling
Updated:  9/26/2015
Joint Clinical Research Center (JCRC)
mi
from
Kampala,
Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations
Status: Enrolling
Updated: 9/26/2015
Joint Clinical Research Center (JCRC)
mi
from
Kampala,
Click here to add this to my saved trials
Developing Newborn Screening for Infants With Primary Immunodeficiency
Developing Newborn Screening for Infants With Primary Immunodeficiency
Status: Enrolling
Updated:  9/26/2015
Yale University
mi
from
New Haven, CT
Developing Newborn Screening for Infants With Primary Immunodeficiency
Developing Newborn Screening for Infants With Primary Immunodeficiency
Status: Enrolling
Updated: 9/26/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma
The Evaluation of Focal Contrast-Enhancing Brain Lesions in HIV-Infected Patients
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma
The Evaluation of Focal Contrast-Enhancing Brain Lesions in HIV-Infected Patients
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
Status: Enrolling
Updated:  9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
Status: Enrolling
Updated: 9/26/2015
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
Exploring Decision Making of Hispanics and African Americans With HIV/AIDS Participating in Clinical Trials
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
Exploring Decision Making of Hispanics and African Americans With HIV/AIDS Participating in Clinical Trials
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Status: Enrolling
Updated:  9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Status: Enrolling
Updated: 9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation and Monitoring of Patients With HIV Infectionn
Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Monitoring of Patients With HIV Infectionn
Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Help Us, Save Us! HIV/STI Risk Reduction for Black Men Who Have Sex With Men
Status: Enrolling
Updated:  9/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Help Us, Save Us! HIV/STI Risk Reduction for Black Men Who Have Sex With Men
Status: Enrolling
Updated: 9/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
Quantification of HIV-1 Reservoirs in HIV-Positive Persons Receiving Response-Adapted Therapy for Stage III-IV Hodgkin Lymphoma: A Companion Protocol to SWOG Protocol S0816 (AMC-073)
Status: Enrolling
Updated:  10/1/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
Quantification of HIV-1 Reservoirs in HIV-Positive Persons Receiving Response-Adapted Therapy for Stage III-IV Hodgkin Lymphoma: A Companion Protocol to SWOG Protocol S0816 (AMC-073)
Status: Enrolling
Updated: 10/1/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Stroger Hospital of Cook County
mi
from
Chicago, IL
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
HIV Out-patient Clinic
mi
from
New Orleans, LA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
HIV Out-patient Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Interim LSU Public Hospital
mi
from
New Orleans, LA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Interim LSU Public Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
NO AIDS Clinic
mi
from
New Orleans, LA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
NO AIDS Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Montefiore Medical Center
mi
from
Bronx, NY
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Montefiore-Einstein Cancer Center
mi
from
Bronx, NY
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Montefiore-Einstein Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Laser Surgery Care
mi
from
New York, NY
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Laser Surgery Care
mi
from
New York, NY
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Harborview Madison Clinic
mi
from
Seattle, WA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Harborview Madison Clinic
mi
from
Seattle, WA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Virginia Mason Medical Center
mi
from
Seattle, WA
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated:  10/1/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Status: Enrolling
Updated: 10/1/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Open-label, Drug-Drug Interaction With Maraviroc
A Phase 1, Open-label, Drug-drug Interaction Study Between BMS-663068 and Maraviroc in Healthy Subjects
Status: Enrolling
Updated:  10/2/2015
ICON Early Phase Services, LLC (formerly named Healthcare Discveries, LLC)
mi
from
San Antonio, TX
A Open-label, Drug-Drug Interaction With Maraviroc
A Phase 1, Open-label, Drug-drug Interaction Study Between BMS-663068 and Maraviroc in Healthy Subjects
Status: Enrolling
Updated: 10/2/2015
ICON Early Phase Services, LLC (formerly named Healthcare Discveries, LLC)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
University of California, San Diego
mi
from
San Diego, CA
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated:  10/5/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated: 10/5/2015
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated:  10/5/2015
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated: 10/5/2015
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated:  10/5/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome
Status: Enrolling
Updated: 10/5/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Rapid HIV Testing Program in the Emergency Department
Pilot Study to Evaluate a Rapid HIV Testing Program in the Emergency Department
Status: Enrolling
Updated:  10/5/2015
Temple University Hospital
mi
from
Philadelphia, PA
Rapid HIV Testing Program in the Emergency Department
Pilot Study to Evaluate a Rapid HIV Testing Program in the Emergency Department
Status: Enrolling
Updated: 10/5/2015
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials